Dr Oz

Commentary

Is the supplement industry in for a reverse Dr Oz effect?

15-Apr-2022 By Hank Schultz

The Senate candidacy of Dr Mehmet Oz, MD, could pose a public relations risk for the dietary supplement industry, as the prominent media personality gets attacked for being a ‘quack’ who has promoted questionable products.

FitLife launches weight loss brand featuring Sabinsa's ForsLean

05-Jan-2016 By Hank Schultz

Dietary supplement manufacturer FitLife Brands has launched a weight-loss product under its iSatori subsidiary that features Sabinsa’s proprietary ForsLean forskohlin as its key ingredient.

Omega-3s, cognitive health, and Dr Oz: NutraIngredients-USA’s top articles of the summer

04-Sep-2014 By Stephen DANIELLS

It’s been an interesting summer for the dietary supplements industry, and we’re taking a look back at some of the lessons from the summer to keep front of mind as we head into the busy fall period.

Dr Oz on ‘The Dr Oz Effect’: For my colleagues at the FTC, I realize I have made their jobs more difficult

17-Jun-2014 By Stephen Daniells

Celebrity doctor Mehmet Oz has admitted that the biggest disservice he has done for his audience is not identifying where to buy the quality products he talks about on his show.

‘The industry is recognizing that spending good dollars gets you good products’: BI Chief on GMPs, adulteration, and the Dr Oz effect

16-Apr-2013 By Stephen DANIELLS

The dietary supplements industry is making ‘heartening’ progress on taking a hard look at raw material sourcing, but GMP issues and adulteration issues continue to cause concern, says the CEO of BI Nutraceuticals.

Dr Oz belly blasting segment prompts sales ‘explosion’ for 7-Keto

17-Apr-2012 By Elaine Watson

Sales of 7-Keto have exploded following a mention on the Dr Oz show in February, with brand owner Humanetics Corp “on track to post triple digit gains this year” for the fat-burning ingredient, should current sales trends continue.

January in pictures: Dr Oz, spiking, cGMPs, krill oil and kiwi fruit

31-Jan-2012 By Elaine Watson

So much for easing gently into the New Year. Just days into 2012, the supplements trade was wrestling with a big spiking story on Dr Oz, more difficult questions about DMAA and calls for even tougher NDI guidance…

‘Shocking and disturbing’ spiking findings on Dr Oz show must be addressed, warns expert

19-Jan-2012 By Elaine Watson

The supplement trade must do more to combat the threat of spiking with unauthorized drugs or its critics will seize upon data unveiled on the Dr Oz show this week as further evidence that the industry is under-regulated, experts have warned.